Kite Lake Capital Management (UK) LLP - CHINA BIOLOGIC PRODS HLDGS I ownership

Quarter-by-quarter ownership
Kite Lake Capital Management (UK) LLP ownership history of CHINA BIOLOGIC PRODS HLDGS I
ValueSharesWeighting
Q3 2020$38,985,000
+26.4%
350,773
+16.2%
38.98%
-18.7%
Q2 2020$30,835,000
+15.3%
301,773
+21.8%
47.96%
+12.4%
Q1 2020$26,742,000
+10.8%
247,773
+19.5%
42.68%
-44.2%
Q4 2019$24,135,000
+74.9%
207,382
+72.0%
76.46%
+7718.1%
Q3 2019$13,802,000
-6.9%
120,573
-38.2%
0.98%
-79.4%
Q4 2018$14,821,000
+21.2%
195,240
+27.7%
4.74%
+87.3%
Q3 2018$12,227,000152,8362.53%
Other shareholders

There were no reported owners of CHINA BIOLOGIC PRODS HLDGS I in Q3 2023.

NameSharesValueWeighting ↓
View complete list of CHINA BIOLOGIC PRODS HLDGS I shareholders